Neuromagen Pharma Announces the Appointment of Professor Gal Ifergane, Head of the Neurology Department at Soroka Medical Center, to its Scientific Advisory Board

Newly formed Scientific Advisory Board will support and advise the company towards submission of in IND and a First-in-Human Clinical Study of AGS-499 for ALS BE’ER SHEVA, Israel, June 23, 2022 /PRNewswire/ — Neuromagen Pharma Ltd., a company developing a new class of drugs for the…